TY - JOUR
T1 - Nebulizer use in inner-city children with asthma
T2 - Morbidity, medication use, and asthma management practices
AU - Butz, Arlene M.
AU - Eggleston, Peyton
AU - Huss, Karen
AU - Kolodner, Ken
AU - Rand, Cynthia
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2000
Y1 - 2000
N2 - Objective: To assess the frequency of nebulizer use, describe morbidity and patterns of medication administration, and examine the potential relationships between inhaled anti-inflammatory medication administration, asthma morbidity, and asthma management practices in children with asthma using a nebulizer compared with children with asthma not using a nebulizer. Research Design: A cross-sectional, descriptive survey of previous events. Setting: Elementary schools and participants' homes in Baltimore, Md, and Washington, DC. Participants: Six hundred eighty-six families of children aged 5 to 12 years with a diagnosis of at least mild, persistent asthma. Interventions: None. Measurements and Main Results: Asthma morbidity, health care utilization, pattern of asthma medication administration, nebulizer use, and asthma management data were collected by telephone survey administered to caregivers. Nebulizer use was defined as use at least 1 or more days per month during the last 6 months. Of 686 children identified, 231 (33%) reported current nebulizer use. Nebulizer users had significantly increased lifetime hospital admissions, hospitalizations, and emergency department visits in the last 6 months compared with nonnebulizer users. Inhaled corticosteroid administration was low for both groups (nonnebulizer users, 8%; nebulizer users, 15%). In the nebulizer users group, administration of inhaled anti-inflammatory medications was associated with increased asthma morbidity (increased hospitalizations, days and nights with symptoms, and oral steroid use). Conclusions: Nebulizer use by inner-city children with asthma is higher than anticipated but is not associated with reduced asthma morbidity. This group of high-risk children was undertreated with inhaled corticosteroids for long-term control of asthma despite reports of adequate monitoring by a primary care physician.
AB - Objective: To assess the frequency of nebulizer use, describe morbidity and patterns of medication administration, and examine the potential relationships between inhaled anti-inflammatory medication administration, asthma morbidity, and asthma management practices in children with asthma using a nebulizer compared with children with asthma not using a nebulizer. Research Design: A cross-sectional, descriptive survey of previous events. Setting: Elementary schools and participants' homes in Baltimore, Md, and Washington, DC. Participants: Six hundred eighty-six families of children aged 5 to 12 years with a diagnosis of at least mild, persistent asthma. Interventions: None. Measurements and Main Results: Asthma morbidity, health care utilization, pattern of asthma medication administration, nebulizer use, and asthma management data were collected by telephone survey administered to caregivers. Nebulizer use was defined as use at least 1 or more days per month during the last 6 months. Of 686 children identified, 231 (33%) reported current nebulizer use. Nebulizer users had significantly increased lifetime hospital admissions, hospitalizations, and emergency department visits in the last 6 months compared with nonnebulizer users. Inhaled corticosteroid administration was low for both groups (nonnebulizer users, 8%; nebulizer users, 15%). In the nebulizer users group, administration of inhaled anti-inflammatory medications was associated with increased asthma morbidity (increased hospitalizations, days and nights with symptoms, and oral steroid use). Conclusions: Nebulizer use by inner-city children with asthma is higher than anticipated but is not associated with reduced asthma morbidity. This group of high-risk children was undertreated with inhaled corticosteroids for long-term control of asthma despite reports of adequate monitoring by a primary care physician.
UR - http://www.scopus.com/inward/record.url?scp=0033798836&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033798836&partnerID=8YFLogxK
U2 - 10.1001/archpedi.154.10.984
DO - 10.1001/archpedi.154.10.984
M3 - Article
C2 - 11030849
AN - SCOPUS:0033798836
VL - 154
SP - 984
EP - 990
JO - JAMA Pediatrics
JF - JAMA Pediatrics
SN - 2168-6203
IS - 10
ER -